Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 19 Stomach Neoplasms 12 Colorectal Neoplasms 10 Rectal Neoplasms 6 Carcinoma, Non-Small-Cell Lung 6 Esophageal Squamous Cell Carcinoma 5 Pancreatic Neoplasms 4 Esophageal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Lung Neoplasms 3 Triple Negative Breast Neoplasms 2 Endometrial Neoplasms 2 Turcot syndrome 1 Thyroid Neoplasms 1 Squamous Cell Non-small Cell Lung Cancer 1 Spinocerebellar Degenerations 1 Sarcoma 1 Salivary Gland Malignant Neoplasms 1 Resectable NSCLC 1 Recurrence 1 Rare Tumor 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Neoplasms 1 NSCLC 1 Microsatellite Stable Metastatic Colorectal Cancer 1 Metastatic Gastroesophageal Junction Adenocarcinoma 1

Interventions

Hyperthermic Intraperitoneal Chemotherapy 2 Gastrectomy 2 taxane 1 sintilimab 1 XELOX 1 Tegafur 1 Taxes 1 Tadalafil 1 Platinum 1 Paclitaxel 1 Oxaliplatin 1 Magnetic Resonance Spectroscopy 1 Immunotherapy, Adoptive 1 Drug Therapy 1 Cytoreduction Surgical Procedures 1 Cisplatin 1 Capecitabine 1 Albumin-Bound Paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Gastric Adenocarcinoma × sintilimab × Clear all

NCT07263386 2025-12-04

ARTEMIS-GC3

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Recruiting

Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡